Neoadjuvant hepatic arterial infusion chemotherapy with FOLFOX could improve outcomes of resectable BCLC stage A/B hepatocellular carcinoma patients beyond Milan criteria: A multi-center, phase 3, randomized, controlled clinical trial.

Wei Wei, Rongping Guo, Rongce Zhao et al.|Journal of Clinical Oncology|2023

Cited by 13